Contract manufacturing pharma player Akums Drugs & Pharmaceuticals Ltd announced that it has received the license to manufacture and commercialise bempedoic acid, a novel, oral non-statin lipid-lowering treatment option. Bempedoic acid is a new class of drug for treating high LDL-cholesterol conditions.
It said that the bempedoic acid is known to be low risk for patients with intolerability for statins and is an important ingredient in most lipid-lowering drugs.
Over 272 out of every lakh of people have heart disease and with every fourth death in India is caused by heart alignment. Of these, some patients may also be intolerant to statins while others may already be prescribed the maximum dose they can tolerate in the course of their treatment. For such patients, bempedoic acid will be a great alternative for doctors.
Sandeep Jain, founder, promoter and director, Akums Drugs & Pharmaceuticals, said that as per statistics, there
